Gottesdiener Keith Michael
Insider CIK 1615856 · ICPT Director · RYTM CEO and President, Director · PRME See Remarks, Director · SEPN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SEPN Septerna, Inc. | A Award deriv | 2026-06-26 | 2026-06-30 | 11,260 | — | $0 | 11,260 | SEC↗ |
| SEPN Septerna, Inc. | A Award deriv | 2025-09-25 | 2025-09-29 | 33,246 | — | $0 | 33,246 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-05-08 | 2025-05-12 | 100,000 | — | $0 | 300,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-02-28 | 2025-03-04 | 500,000 | — | $0 | 500,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2024-12-05 | 2024-12-09 | 100,000 | — | $0 | 200,000 | SEC↗ |
| PRME Prime Medicine, Inc. | G Gift | 2024-10-08 | 2024-10-10 | 226,925 | — | $0 | 682,259 | SEC↗ |
| PRME Prime Medicine, Inc. | G Gift | 2024-10-08 | 2024-10-10 | 226,925 | — | $0 | 50,241 | SEC↗ |
| PRME Prime Medicine, Inc. | G Gift | 2024-06-05 | 2024-06-07 | 250,000 | — | $0 | 2,310,837 | SEC↗ |
| PRME Prime Medicine, Inc. | G Gift | 2024-06-05 | 2024-06-07 | 250,000 | — | $0 | 277,166 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2024-02-25 | 2024-02-27 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PRME Prime Medicine, Inc. | G Gift | 2023-11-11 | 2023-11-14 | 5,000 | — | $0 | 27,166 | SEC↗ |
| PRME Prime Medicine, Inc. | G Gift | 2023-11-11 | 2023-11-14 | 7,500 | — | $0 | 2,560,837 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 12,547 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 12,089 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 12,790 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,966 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,174 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,748 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,036 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 3,196 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer | 2023-11-08 | 2023-11-13 | 8,111 | $19.00 | $154.1K | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | U Tender | 2023-11-08 | 2023-11-13 | 24,719 | $19.00 | $469.7K | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2023-05-24 | 2023-05-25 | 12,547 | — | $0 | 12,547 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2023-05-24 | 2023-05-25 | 8,111 | — | $0 | 32,830 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2023-03-31 | 2023-04-04 | 497,738 | — | $0 | 497,738 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2022-05-25 | 2022-05-27 | 12,790 | — | $0 | 12,790 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2022-05-25 | 2022-05-27 | 7,737 | — | $0 | 24,719 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2021-05-27 | 2021-06-01 | 12,089 | — | $0 | 12,089 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-05-27 | 2021-06-01 | 7,029 | — | $0 | 16,982 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2020-05-28 | 2020-06-01 | 2,966 | — | $0 | 2,966 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2020-05-28 | 2020-06-01 | 1,595 | — | $0 | 9,953 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2020-03-09 | 2020-03-11 | 3,408 | — | $0 | 207,877 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2020-03-09 | 2020-03-11 | 3,408 | $6.14 | $20.9K | 558,250 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2020-02-10 | 2020-02-12 | 6,816 | — | $0 | 211,286 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2020-02-10 | 2020-02-12 | 6,816 | $6.14 | $41.9K | 554,283 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2020-01-08 | 2020-01-10 | 33,072 | — | $0 | 84,208 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2020-01-08 | 2020-01-10 | 33,072 | $4.59 | $151.8K | 546,914 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2019-07-16 | 2019-07-17 | 7,500 | — | $0 | 117,280 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2019-07-16 | 2019-07-17 | 7,500 | $4.59 | $34.4K | 513,842 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2019-06-20 | 2019-06-21 | 2,174 | — | $0 | 2,174 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2019-06-20 | 2019-06-21 | 1,570 | — | $0 | 8,358 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-03-18 | 2019-03-19 | 2,329 | $30.27 | $70.5K | 506,342 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-03-15 | 2019-03-19 | 7,961 | $30.04 | $239.1K | 508,671 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-03-14 | 2019-03-15 | 1,506 | $30.05 | $45.3K | 516,632 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-03-13 | 2019-03-15 | 7,782 | $30.06 | $233.9K | 518,138 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-02-27 | 2019-02-28 | 1,814 | $30.01 | $54.4K | 525,617 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-02-26 | 2019-02-28 | 635 | $30.13 | $19.1K | 527,431 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-02-19 | 2019-02-20 | 918 | $30.05 | $27.6K | 528,066 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-02-15 | 2019-02-20 | 12,002 | $30.02 | $360.3K | 528,984 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2019-02-13 | 2019-02-15 | 225,000 | — | $0 | 225,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-02-13 | 2019-02-15 | 3,934 | $30.00 | $118.0K | 540,986 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-01-23 | 2019-01-24 | 105 | $30.21 | $3.2K | 544,920 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-01-22 | 2019-01-24 | 15,674 | $30.05 | $471.0K | 545,025 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-01-18 | 2019-01-22 | 10,115 | $30.01 | $303.6K | 560,699 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-01-16 | 2019-01-17 | 662 | $30.00 | $19.9K | 570,814 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2018-12-03 | 2018-12-06 | 563 | $30.00 | $16.9K | 571,476 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2018-11-02 | 2018-11-06 | 16,500 | $30.08 | $496.3K | 572,039 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2018-06-20 | 2018-06-22 | 2,748 | — | $0 | 2,748 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2018-06-20 | 2018-06-22 | 1,787 | — | $0 | 6,788 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2018-05-09 | 2018-05-10 | 3,000 | — | $0 | 124,780 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2018-05-09 | 2018-05-10 | 3,000 | $4.59 | $13.8K | 588,539 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | P Buy | 2018-04-09 | 2018-04-09 | 1,171 | $64.00 | $74.9K | 5,001 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2018-02-14 | 2018-02-16 | 175,000 | — | $0 | 175,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 27,262 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 27,262 | — | $0 | 585,539 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2017-06-27 | 2017-06-29 | 2,036 | — | $0 | 2,036 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2017-06-27 | 2017-06-29 | 1,423 | — | $0 | 3,830 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2016-07-19 | 2016-07-21 | 3,196 | — | $0 | 3,196 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2016-07-19 | 2016-07-21 | 2,407 | — | $0 | 2,407 | SEC↗ |